MedTrace Logo

Study of NeuroAid In Enhancing Recovery After Stroke

NCT00721825 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2008-07-24

No results posted yet for this study

Summary

TIERS is a phase II to generate detailed preliminary data on the efficacy of NeuroAid in post-stroke recovery, and to assess the utility of the rehabilitation outcome measure instruments used.

Conditions

Interventions

DRUG

Neuroaid

Neuroaid capsules, 4 capsules, three times per day, during one month

DRUG

Neuroaid matched Placebo

Neuroaid matched placebo 4 capsules three times per day during one month

Sponsors & Collaborators

  • Moleac Pte Ltd.

    lead INDUSTRY

Principal Investigators

  • Keng He Kong, MD · Tan Tock Seng Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00721825 on ClinicalTrials.gov